Palisades Investment Partners, LLC Adma Biologics, Inc. Transaction History
Palisades Investment Partners, LLC
- $229 Billion
- Q2 2025
A detailed history of Palisades Investment Partners, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Palisades Investment Partners, LLC holds 398,647 shares of ADMA stock, worth $6.59 Million. This represents 3.17% of its overall portfolio holdings.
Number of Shares
398,647
Previous 410,446
2.87%
Holding current value
$6.59 Million
Previous $8.14 Billion
10.85%
% of portfolio
3.17%
Previous 4.09%
Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
395Shares Held
194MCall Options Held
2.53MPut Options Held
746K-
Vanguard Group Inc Valley Forge, PA21.4MShares$353 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$308 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$213 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$189 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$97.7 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.24B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...